Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lurasidone vs risperidone in schizophrenia (CTR20150780)
CTR20150780Phase 3Active
- Sponsor
- Hengrui Therapeutics
- Start
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lurasidone in schizophrenia, sponsored by Hengrui Therapeutics. Started Nov 2015; status: active.
02
Drugs
lurasidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on CTR20150780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150780.